Quarterly ResultMar 29, 2026, 09:15 PM
Thermo Fisher Scientific Reports Q4 2025 Revenue Up 7% to $12.21 Billion, Adjusted EPS Up 8% to $6.57
AI Summary
Thermo Fisher Scientific reported its Q4 and full-year 2025 financial results. Q4 revenue increased by 7% to $12.21 billion, and adjusted EPS grew by 8% to $6.57, indicating strong financial performance. The company also highlighted strategic collaborations, acquisitions, and product launches, demonstrating continued growth and innovation.
Key Highlights
- Q4 revenue grew 7% to $12.21 billion.
- Q4 GAAP diluted EPS grew 9% to $5.21.
- Full year revenue grew 4% to $44.56 billion.
- Announced a strategic collaboration with OpenAI to expand the use of artificial intelligence.
- Completed the acquisition of the Filtration and Separation business from Solventum and Sanofi’s Ridgefield, New Jersey, sterile fill-finish site.
Price Impact
More from TMO